| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| HALAZEPAM DISCONTINUED (has an active metabolite)
| HALAZEPAM | NERVOUS SYSTEM | ORAL | VD 732 LITER (EQN) Cl 24 LITER / HOUR (PMID1980307) HT 21.15 HOUR | GAMMA-AMINOBUTYRIC-ACID RECEPTOR | GABA-A RECEPTOR ANION CHANNEL POSITIVE ALLOSTERIC MODULATOR CHEMBL2093872 GABA-A RECEPTOR ANION CHANNEL P14867 GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT ALPHA-1 HOMO SAPIENS ION CHANNEL LGIC GABAA | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M DIAZEPAM (is an active metabolite) (has an active metabolite)
| DIAZEPAM | NERVOUS SYSTEM | - | VD 29.2 LITER (65 KILOGRAM) PPB 97 PERCENT Cl 0.46 LITER / HOUR (65 KILOGRAM) HT 46 HOUR | GAMMA-AMINOBUTYRIC-ACID RECEPTOR | GABA-A RECEPTOR ANION CHANNEL POSITIVE ALLOSTERIC MODULATOR CHEMBL2093872 GABA-A RECEPTOR ANION CHANNEL P14867 GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT ALPHA-1 HOMO SAPIENS ION CHANNEL LGIC GABAA | EMA | |||
